Cargando…
Immunogenicity of COVID-19 vaccines in patients with hematologic malignancies: a systematic review and meta-analysis
The objectives of this study were to assess the immunogenicity and safety of COVID-19 vaccines in patients with hematologic malignancies. A systematic review and meta-analysis of clinical studies of immune responses to COVID-19 vaccination stratified by underlying malignancy and published from Janua...
Autores principales: | Teh, Joanne S. K., Coussement, Julien, Neoh, Zoe C. F., Spelman, Tim, Lazarakis, Smaro, Slavin, Monica A., Teh, Benjamin W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Hematology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8639290/ https://www.ncbi.nlm.nih.gov/pubmed/34852173 http://dx.doi.org/10.1182/bloodadvances.2021006333 |
Ejemplares similares
-
Interventions to reduce infections in patients with hematological malignancies: a systematic review and meta-analysis
por: Chai, Khai Li, et al.
Publicado: (2022) -
Immunogenicity and Safety of Childhood Combination Vaccines: A Systematic Review and Meta-Analysis
por: Liu, Bei, et al.
Publicado: (2022) -
Weak immunogenicity of SARS-CoV-2 vaccine in patients with hematologic malignancies
por: Malard, Florent, et al.
Publicado: (2021) -
Evolution of Humoral and Cellular Immunity Post–Breakthrough Coronavirus Disease 2019 in Vaccinated Patients With Hematologic Malignancy Receiving Tixagevimab-Cilgavimab
por: Hall, Victoria G, et al.
Publicado: (2023) -
Anticancer Therapy and Mortality of Adult Patients with Hematologic Malignancy and COVID-19: A Systematic Review and Meta-Analysis
por: Lin, Wen-Li, et al.
Publicado: (2023)